Impact of Respiratory Viral Infections in Transplant Recipients

Resource type
Journal Article
Authors/contributors
Title
Impact of Respiratory Viral Infections in Transplant Recipients
Abstract
Respiratory viral infections (RVIs) are among the leading cause of morbidity and mortality in pediatric hematopoietic stem cell transplant (HCT) and solid organ transplant (SOT) recipients. Transplant recipients remain at high risk for super imposed bacterial and fungal pneumonia, chronic graft dysfunction, and graft failure as a result of RVIs. Recent multicenter retrospective studies and prospective studies utilizing contemporary molecular diagnostic techniques have better delineated the epidemiology and outcomes of RVIs in pediatric transplant recipients and have advanced the development of preventative vaccines and treatment interventions in this population. In this review, we will define the epidemiology and outcomes of RVIs in SOT and HSCT recipients, describe the available assays for diagnosing a suspected RVI, highlight evolving management and vaccination strategies, review the risk of donor derived RVI in SOT recipients, and discuss considerations for delaying transplantation in the presence of an RVI.
Publication
Journal of the Pediatric Infectious Diseases Society
Volume
13
Issue
Supplement_1
Pages
S39-S48
Date
2024-02-01
Journal Abbr
Journal of the Pediatric Infectious Diseases Society
ISSN
2048-7207
Accessed
3/17/24, 10:21 AM
Library Catalog
Silverchair
Citation
Bahakel, H., Waghmare, A., & Madan, R. P. (2024). Impact of Respiratory Viral Infections in Transplant Recipients. Journal of the Pediatric Infectious Diseases Society, 13(Supplement_1), S39–S48. https://doi.org/10.1093/jpids/piad094
SOLID ORGANS AND MCSS
Link to this record